The trade relationship between Canada and the United States, already under strain from months of negotiations, hit another turbulent phase this week after U.S. President Donald Trump announced a steep 35% tariff on Canadian goods, citing an alleged “flow of fentanyl” from Canada. In response, Canadian Prime Minister Mark Carney issued a firm rebuttal, asserting that Canada has taken significant measures to curb opioid trafficking and remains committed to working with the U.S. to combat the fentanyl crisis in North America.
The escalating tariff, which will take effect on August 1, is part of a broader protectionist push by Trump, who is pursuing aggressive trade realignment policies as part of his 2025 re-election campaign. The move has triggered widespread concern among Canadian businesses, border trade experts, and public health officials on both sides of the border.
